1. European Commission. Pharmaceutical strategy for Europe. 2020. https://ec.europa.eu/health/sites/health/files/human-use/docs/pharma-strategy_report_en.pdf. Accessed 22 Apr 2021.
2. Bartels HG, World Health Organization, World Intellectual Property Organization, et al., editors. Promoting access to medical technologies and innovation: intersections between public health, intellectual property, and trade. Geneva: World Health Organization, World Intellectual Property Organization, World Trade Organization; 2013. https://www.who.int/phi/PAMTI_WHO-WIPO-WTO.pdf. Accessed 20 Oct 2020.
3. European Commission. Pharmaceutical strategy for Europe Workshop summary, 14-15 July 2020. 2020. https://ec.europa.eu/health/sites/health/files/human-use/docs/stakeholders_sum_workshop_en.pdf. Accessed 14 Oct 2020.
4. Vreman RA, Heikkinen I, Schuurman A, et al. Unmet medical need: an introduction to definitions and stakeholder perceptions. Value Health. 2019;22:1275–82. https://doi.org/10.1016/j.jval.2019.07.007.
5. Saesen R, Lejeune S, Quaglio G, et al. Views of European drug development stakeholders on treatment optimization and its potential for use in decision-making. Front Pharmacol. 2020;11:43. https://doi.org/10.3389/fphar.2020.00043.